September 23, 2013
FDA bans Ranbaxy imports – again – for pharma manufacturing concerns
For the third time in five years, the U.S. Food and Drug Administration has blocked imports of medicine from a Ranbaxy Laboratories Ltd. plant in India for manufacturing violations. The latest ban involves...
Posted In Whistleblower Law Insights
September 16, 2013
Vanderbilt University hospital accused of failing to supervise doctors and nurses in training during surgeries
A “qui tam” lawsuit against the Vanderbilt University Medical Center that was unsealed last week contained a particularly disturbing allegation: It cited an incident where an unsupervised student nurse...
Posted In Whistleblower Law Insights
September 13, 2013
Bayer AG is the latest pharma company to acknowledge it is being investigated by Chinese authorities for its marketing and sales practices in China
Given the growing number of pharma companies in China under investigation for bribery and corruption, it’s becoming more a question of who isn’t being investigated, rather than who is. Pharma companies...
Posted In Whistleblower Law Insights
September 11, 2013
Glaxo getting squeezed by three countries for pharma marketing practices in China
After getting slapped by the U.S. in 2012 for its marketing practices, GlaxoSmithKline now is getting pummeled by China, the UK, and the U.S. which are investigating Glaxo for its pharma marketing practices...
Posted In Whistleblower Law Insights
April 24, 2013
Review of Barclays fails to recognize role whistleblowers can play in compliance
A recent independent report on British bank Barclays corporate culture, known as the Salz Review, addresses the impact some employees’ conduct has had on the bank’s reputation. It does not, however,...
Posted In Whistleblower Law Insights
March 27, 2013
Texas reaps rewards of whistleblower cases
A new report issued by the Taxpayers Against Fraud Education Fund highlights the substantial benefits states realize from adopting false claims laws. Fighting Medicaid Fraud in Texas, authored by economists...
Posted In Whistleblower Law Insights
February 12, 2013
P&C attorney discusses Calif. AG’s strategy in charging S&P with False Claims Act violations
The U.S. Dept. of Justice and more than a dozen states have filed suit against Standard & Poor’s, alleging that the firm’s inflation of mortgage investments cost investors billions when...
Posted In Whistleblower Law Insights
February 05, 2013
Whistleblower attorney finds tone at top of SEC and CFTC encouraging for whistleblowers
The whistleblower programs at the Securities and Exchange Commission and the Commodity Futures Trading Commission are working “incredibly well,” according to Phillips and Cohen partner Erika Kelton....
January 17, 2013
Payments to settle fraud charges shouldn’t be tax deductible
Several banks that recently settled cases for mortgage abuses will be able to deduct those settlement payments as “business expenses,” making those settlements less painful for the banks than they...
December 04, 2012
Whistleblowers help government recover record $5 billion in FY2012
The government recovered a record-breaking $5 billion in FY 2012 under the False Claims Acts, a top Justice Department official announced today. Principal Deputy Assistant Attorney General Stuart Delery...
Posted In Whistleblower Law Insights